Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

PRE-ART VIRAL LOAD IS PREDICTIVE OF LYMPH NODE ART LEVELS IN SIV-INFECTED MACAQUES

By Jimmy He PharmD, DScApril 22, 2021

Using dual-photon in-vivo imaging, we previously showed significantly lower concentrations of tenofovir (TFV) in rat lymph nodes (LN) compared to peripheral blood (PB). This finding was later confirmed for intracellular…

INTEGRASE AND PROTEASE INHIBITOR CONCENTRATIONS IN LYMPHOID VS GI TISSUES

By Enthusiast Inc MDFebruary 15, 2017

…DRV, 4 ATV), with a subset with ileal (2 RAL, 1 DRV, 1 ATV) and lymph node (2 RAL, 1 DRV) samples. The median age was 44 years and median…

DIGITAL SPATIAL PROFILING OF FIBROTIC LYMPH NODE MICROENVIRONMENTS IN CHRONIC HIV

By Jimmy He PharmD, DScApril 22, 2021

…Medicine. A portion of each LN was formalin-fixed, paraffin-embedded (FFPE) and slide-mounted tissue sections were prepared. H&E staining was performed on LN slides and fibrotic regions were quantified by a…

395 – First-Line DTG+3TC Reaches Lymph Nodes and Reduces HIV Reservoir Comparable to DTG+FTC/TAF

By Jimmy He PharmD, DScMarch 31, 2026

…detectable, although LC-MS/MS confirmed TFV-dp and FTC-tp concentrations exceeding EC50 (36.7 and 29.6 fmol/106 cells, respectively); so spatial analysis focused on 2DR. Spatial measurement of DTG+3TC indicated exposure of ≥1…

512 – RV550: Safety and Virologic Outcomes in Blood and Lymph Nodes of N-803 With ART in Acute Infection

By Jimmy He PharmD, DScMarch 20, 2025

…vDNA and vRNA in CD4 T cells and lymph nodes (LN). Methods We randomized 12 participants in AHI to receive immediate ART (n=4, Fiebig 1-2) or ART + N-803 (n=8,…

PROFILING THE PROVIRAL LANDSCAPE IN TISSUES FROM ART-TREATED INDIVIDUALS

By Jimmy He PharmD, DScApril 22, 2021

…disseminated across lymph node, spleen, and kidney. Ten large clones of defective proviruses were also noticed, which were broadly distributed across lymph node, spleen, the CNS, the genitourinary system, and…

Association of Gag-Specific CD28+CD95+ CD8+ T-Cell Responses in Lymph Nodes With Lower Viral Loads

By Enthusiast Inc MDSeptember 29, 2014

…We examined viral protein-specific CD8+ T-cell responses in these PBMCs and LN-derived lymphocytes by detection of IFN-γ induction after stimulation with overlapping peptide pools and performed correlation analyses between these…

MASS SPEC IMAGING REVEALS ASSOCIATIONS BETWEEN ARVS, VIRUS, AND CELLS IN LYMPH NODES

By Enthusiast Inc MDMarch 5, 2018

…or maraviroc (MVC) + atazanavir (ATZ) (N=3), cohort 2. Tissue accumulation of ARVs and metabolites was measured by LC-MS/MS (analyte-specific limits of detection [LOD]: 1-8 ng/ml homogenate) and infrared matrix-assisted…

521 – HIV-1 Clade C Reservoir Traits in Blood and Lymph Node Tissue in Acute and Chronic Treated Infection

By Jimmy He PharmD, DScMarch 20, 2025

…(median days after diagnosis =424, IQR 141-719; median days on ART =899, IQR 405-1567), 5 during acute infection (AT) (median days after diagnosis =1, IQR 0.5-1; median days on ART…

404 – Lymph Node Tfh Cells Form a Clonally Expanded, Epigenetically Active HIV Reservoir During ART

By Jimmy He PharmD, DScMarch 31, 2026

…both active and repressive chromatin compared with PBMC-derived CD4⁺ T cells (H3K27ac: p=0.0015; H3K9me3: p<0.0001; H3K27me3: p=0.0007). Conclusions This study provides the first evidence that LN-derived Tfh cells harbor clonally…

←1
2345678910111213141516171819202122232425
…2627282930…
31323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top